MADRID – “Rituximab has a superior overall benefit/risk profile, compared to mycophenolate mofetil, in patients with moderate to severe pemphigus...
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
Scoring systems are emerging in dermatology to help guide clinical decision-making. This article discusses 4 scoring systems that help...
From the Journals
Delayed puberty and growth failure were observed in children with juvenile dermatomyositis.
AUSTIN, TEX. – Referral to a patient support group is key to coping.
A 51-year-old black woman presented to the dermatology clinic with painful and pruritic erosions on the back, abdomen, neck, and arms of...
Gliflozins are a new class of medications used for treatment of type 2 diabetes mellitus. This case report of dapagliflozin-induced Sweet syndrome...
A 55-year-old man presented with red-violet patches on the right arm and chest that had been present since birth. The patches were asymptomatic...
MILAN – Promising early clinical work has paved the way for a global phase 3 trial.
The approval is based on the results of the randomized, placebo-controlled, double-blind, phase 3 RELIEF trial.